Since chromatin organization is a major contributor to mutation rates in the genome [25], we also included global chromatin accessibility data as measured by high-throughput sequencing of DNase I hypersensitive sites (DNase-seq) in MCF-7 breast cancer cells, which are ER-positive. Here, ESR1 is linked to breast cancer.